Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
BIIB
BIIB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BIIB News
Biogen Elects New Chair of the Board
3d ago
Newsfilter
Biogen Elects Dr. Maria C. Freire as New Chair of the Board
3d ago
Yahoo Finance
Biogen Reports Q4 and Full Year 2025 Earnings Exceeding Expectations
6d ago
Newsfilter
Biogen Reports Better-Than-Expected Q4 Results
6d ago
Benzinga
Biogen Reports Strong Q4 Earnings, Beats Expectations
6d ago
Benzinga
Wall Street Analysts Adjust Ratings
6d ago
Benzinga
China Grants Priority Review for Biogen and Eisai's Alzheimer's Treatment
6d ago
stocktwits
LEQEMBI® Receives Priority Review in China
6d ago
Newsfilter
LEQEMBI® Receives Priority Review in China
6d ago
Yahoo Finance
Biogen's 2025 Financials Exceed Expectations
Feb 08 2026
NASDAQ.COM
Biogen Reports 2025 Earnings Exceeding Expectations
Feb 07 2026
Fool
Biogen Inc. Reports Strong Q4 2025 Earnings with Growth Products Driving Revenue
Feb 06 2026
seekingalpha
Biogen Reports Strong Earnings, Optimistic Outlook Ahead
Feb 06 2026
Benzinga
Biogen Shares Increase Despite Falling Multiple Sclerosis Revenue and Ongoing Declines
Feb 06 2026
Barron's
Biogen Q4 Earnings Beat Expectations
Feb 06 2026
seekingalpha
Biogen Reports Strong Q4 2025 Earnings but Projects Revenue Decline for 2026
Feb 06 2026
seekingalpha
Show More News
